Free Content:

Reviews+ S. x3 {0 D. @: p5 W/ v) T  `# `- V7 Z: W
: {# v* p' l; q. [' J( x, f9 i9 z
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery
( L) i% L! i+ I  X6 P' R% eKeiran SM Smalley, Mercedes Lioni, Kazuhiro Noma, Nikolas K Haass, Meenhard Herlyn; W( w) T$ Z3 S
Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 1-10.
- q9 x) b# h4 S5 ~; l( f* f# w) m
! s2 r9 G8 B8 t7 x" d! I- UTargeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone, W, E  x* L* m+ G
Mark Pines
* Z* V1 T) i5 J& e: W* oExpert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 11-20.
: v1 l' [3 Y$ l4 z! Q7 X
; _1 b9 ?5 h8 m3 }Development of new antituberculous agents based on new drug targets and structure–activity relationship
; C4 i% i6 R! ]& X; kHaruaki Tomioka
7 _) T* k) A) O* w" C6 L! t* \Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 21-49.
6 L+ K8 `" ~, r; s 5 v3 i$ w) D2 \2 z$ x5 e
The apelin peptides as putative targets in cardiovascular drug discovery and development8 n7 a  s8 B8 v3 h6 t
CJ Charles
: M: n$ P: D6 t$ kExpert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 51-64.
& x1 O2 X+ }3 l7 E) @3 q& K* @6 Q3 v4 ?
- N% X8 F' U" K. l1 XHuprines for Alzheimer's disease drug development
: l/ g: t! Z# q5 ~/ H* YDiego Muñoz-Torrero, Pelayo Camps' W7 i! g$ u; D0 b& E9 r
Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 65-81.
8 X( n  ?7 t$ V/ O* v0 n# H, ~3 fSummary | Full Text | PDF (1407 KB) | PDF Plus (1560 KB) 5 R% q' y' M. l6 j0 V0 f

9 J. F! Z- o- q. |4 tAnimal models for drug discovery in dystonia
$ G0 [1 H' w7 T1 d3 b& ~, YHA Jinnah, Angelika Richter, Jonathon W Mink, Guy A Caldwell, Kim A Caldwell, Pedro Gonzalez-Alegre, Mark R Cookson, Xandra O Breakefield, Mahlon R Delong, Ellen J Hess7 _. m$ Q0 B9 G9 {# J* k3 L
Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 83-97.$ {; ~3 `3 L: b& {+ \5 v3 I
( O- @, G! s" q# s3 S3 L3 d
Discovery and development of purine-scaffold Hsp90 inhibitors
7 j6 Y. ^, a9 `9 ?3 BGabriela Chiosis, Yanlong Kang, Weilin Sun  p3 E3 t8 ]8 W4 K$ J% V8 J* K
Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 99-114.
+ u4 }/ P& s3 U1 g' t) S
1 o$ v( z6 b1 J2 R* uDeveloping assays for kinase drug discovery – where have the advances come from?( E; s- G" a- h( O& ^
Kurt W Vogel, Zhong Zhong, Kun Bi, Brian A Pollok6 U" H( l- o0 g7 S" g
Expert Opinion on Drug Discovery, January 2008, Vol. 3, No. 1, Pages 115-129.
1 Y  C# I" c$ K7 _" `+ W9 o0 n) [ 6 U6 P) k) v! k/ R. `
Case History; ]/ E3 x( t# j2 A% x9 S1 r3 c/ R
8 g" I9 C$ ^3 q+ S* o  A% h2 T
Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases

/ K" h1 y1 A# i% ~" J) v0 c
0 u" z. _6 V! S* AUploaded to ITECH site: d3 o3 t3 A' T5 g" G% ^
/ O6 B4 w) k  ~' ^
[ Last edited by blega at Sep 19, 2008 17:12 ]

how much size is it???can you upload them into our forum?

Not big, it is ~5 MB in a  zipped archive.* W1 M5 I! T$ b- O
Upload here?

thanks very much

thank you very  much

The file could not be found. Please check the download link

The file could not be found. Please check the download link
' e( r# X( Q7 Z* G* r# S$ K- s' e  _% S( P, v
[ Last edited by shihaifu at Sep 09, 2008 10:17 ]

thank you very much...

The file could not be found. Please check the download link

thank you very much...

thank you very much...

try again.